MoneyWorks4Me

The quarter ended September 2023 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 18680.00 millions.The Net proft of the company remain more or less same to Rs. 3420.00  millions from Rs. 4870.00 millions ,decline by -29.77%.Operating profit for the quarter ended September 2023 decreased to 5590.00 millions as compared to 6880.00 millions of corresponding quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 18680.00 18230.00 2.47 35980.00 40270.00 -10.65 76253.00 88798.20 -14.13
Other Income 850.00 790.00 7.59 1650.00 1690.00 -2.37 3490.10 1112.60 213.69
PBIDT 5590.00 6880.00 -18.75 11300.00 16150.00 -30.03 26966.90 39877.20 -32.38
Interest 10.00 0.00 0.00 10.00 0.00 0.00 5.20 6.50 -20.00
PBDT 5580.00 6880.00 -18.90 11290.00 16150.00 -30.09 26961.70 39870.70 -32.38
Depreciation 940.00 850.00 10.59 1870.00 1680.00 11.31 3420.70 3105.50 10.15
PBT 4640.00 6030.00 -23.05 9420.00 14470.00 -34.90 23541.00 36765.20 -35.97
TAX 1220.00 1160.00 5.17 2550.00 2690.00 -5.20 5459.50 7279.80 -25.00
Deferred Tax 140.00 260.00 -46.15 240.00 410.00 -41.46 1083.70 907.80 19.38
PAT 3420.00 4870.00 -29.77 6870.00 11780.00 -41.68 18081.50 29485.40 -38.68
Equity 530.00 530.00 0.00 530.00 530.90 -0.17 530.90 530.90 0.00
PBIDTM(%) 29.93 37.74 -20.71 31.41 40.10 -21.69 35.37 44.91 -21.25
Peers
Company Name CMP
Sun Pharma. Inds. 1759.10
Dr. Reddys Labs. 1230.50
Cipla 1313.70
Lupin 1946.00
Zydus Lifesciences 1139.00
View more..